Codexis Inc (CDXS)
2.90
+0.04
(+1.40%)
USD |
NASDAQ |
Apr 23, 16:00
2.90
0.00 (0.00%)
After-Hours: 20:00
Codexis Cash from Operations (TTM): -52.64M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -52.64M |
September 30, 2023 | -36.68M |
June 30, 2023 | -0.648M |
March 31, 2023 | 13.26M |
December 31, 2022 | 11.28M |
September 30, 2022 | 7.027M |
June 30, 2022 | -12.90M |
March 31, 2022 | -19.01M |
December 31, 2021 | -14.27M |
September 30, 2021 | -16.42M |
June 30, 2021 | -19.70M |
March 31, 2021 | -21.48M |
December 31, 2020 | -16.46M |
September 30, 2020 | -18.63M |
June 30, 2020 | -16.15M |
March 31, 2020 | -11.13M |
December 31, 2019 | -12.56M |
September 30, 2019 | -9.619M |
June 30, 2019 | -9.862M |
March 31, 2019 | -12.76M |
December 31, 2018 | -14.09M |
September 30, 2018 | -5.748M |
June 30, 2018 | -9.365M |
March 31, 2018 | -9.374M |
December 31, 2017 | -8.755M |
Date | Value |
---|---|
September 30, 2017 | -11.22M |
June 30, 2017 | -13.58M |
March 31, 2017 | -5.645M |
December 31, 2016 | -1.86M |
September 30, 2016 | 0.133M |
June 30, 2016 | 7.774M |
March 31, 2016 | 3.634M |
December 31, 2015 | -0.433M |
September 30, 2015 | -2.615M |
June 30, 2015 | -1.36M |
March 31, 2015 | -1.122M |
December 31, 2014 | 0.321M |
September 30, 2014 | -8.558M |
June 30, 2014 | -18.78M |
March 31, 2014 | -21.92M |
December 31, 2013 | -23.00M |
September 30, 2013 | -23.83M |
June 30, 2013 | -19.16M |
March 31, 2013 | -15.97M |
December 31, 2012 | -11.89M |
September 30, 2012 | -10.05M |
June 30, 2012 | -3.439M |
March 31, 2012 | -7.183M |
December 31, 2011 | -0.49M |
September 30, 2011 | 2.075M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-52.64M
Minimum
Dec 2023
13.26M
Maximum
Mar 2023
-13.51M
Average
-14.27M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Sutro Biopharma Inc | -111.62M |
Avidity Biosciences Inc | -119.06M |
Taysha Gene Therapies Inc | -73.02M |
Janux Therapeutics Inc | -50.58M |
Tango Therapeutics Inc | -117.98M |